Clinical trial
The Role of the EKG in Anticancer Phase I Drug Development
NCT01462383 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of the EKG in Anticancer Phase I Drug Development
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- November 30, 2011
- Enrollment
- 525 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer